NL
DE
Together with a consortium of European researchers, neurologist and Radboudumc PI Bart van de Warrenburg and RIHS researcher Marjan Meinders have received a 2 million euro grant for research into rare neurological movement disorders: spastic ataxia. The grant is part of the European Joint Programme on Rare Diseases (EJP-RD). The Radboudumc is a recognized expert centre for rare and genetic movement disorders, including ataxia.
The PROSPAX consortium will develop new tools to track progression of these diseases, such as blood-based biomarkers, specific MRI measurements and wearable technology. The Radboudumc and Donders team will lead the work on wearables, and they will design algorithms that, based on data collected through smartphones and smartwatches, reliably track progression of disease. The ultimate aim is to develop an app that integrates the sensoring data and algorithms, and that can be used as a tool to monitor disease progression in future clinical trials.
The Expert centre for Parkinson & Movement disorders of the Radboudumc has a lot of experience with wearable technology research, and the team will now exploit this knowledge for ataxia.
Related news items
Palliative care for people with Parkinson’s Disease and their family Caregivers Current state of affairs
7 October 2021 Advanced stage Parkinson’s disease can cause a variety of symptoms, for which palliative care can be beneficial, though research from the point of view of patients in later stages is still rare. Radboudumc researchers therefore placed their patients perspectives at the center of their recent study. read more
Grants for science communication at Radboudumc
22 April 2021 Scientists at the Radboudumc have received two KNAW grants, each worth 10,000 euros, for science communication. With the new fund, KNAW underlines importance of making science accessible. read more
Simple tool provides insight into the average life expectancy for patients with dementia
19 December 2019 A simple tool can quickly provide patients, with a dementia diagnosis, with more clarity about their average life expectancy. This tool is developed by Radboudumc in collaboration with the Karolinska Institute in Sweden. read more
Self-management rehabilitation program improves participation in patients with neuromuscular disease
4 November 2019 Yvonne Veenhuizen, Alexander Geurts theme Neurorehabilitation, Baziel van Engelen, theme Disorders of movement, and colleagues, showed that Energetic improves participation in patients with neuromuscular disease. They have published their results in Neurology. read more
Careful prescription of addictive painkillers still necessary
19 September 2019 Although the use of opioid painkillers in the Netherlands has risen over the past ten years, it is nowhere near the degree to which they are used in the United States, say Arnt Schellekens and his colleagues in an article published in The Lancet Public Health. read more
